NCT03543917View on ClinicalTrials.gov

Post-Stroke Improvement of Motor Function

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 8, 2017

Primary Completion Date

August 30, 2018

Study Completion Date

September 29, 2018

Conditions

Cerebrovascular Accident

Interventions

COMBINATION_PRODUCT

Perfusion with New Combination Medication

Intravenous administration of Actovegin, vitamins B1, B6, B12, C, oxytocin/dexamethasone, calcium gluconate, etc in 250 ml normal saline administered during approximately 2 hours

Trial Locations (1)

040245

Fundatia Bio-Forum, Bucharest

All Listed Sponsors

lead

Fundatia Bio-Forum

OTHER

NCT03543917 - Post-Stroke Improvement of Motor Function | Biotech Hunter | Biotech Hunter